SMTL ID : 3olf.2 (1 other biounit)

Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3-methylbenzoic acid

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

hetero-1-1-mer

Ligands

1 x OLF: 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3-methylbenzoic acid(Non-covalent)

OLF.1: 19 residues within 4Å: Chain A: I.30, T.31, I.34, N.44, L.48, M.51, A.52, H.55, M.89, F.90, R.92, S.93, I.96, F.97, L.109, I.113, S.116, M.126, Y.130 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:I.34, A:L.48, A:L.48, A:M.51, A:F.90, A:R.92, A:I.96, A:I.113, A:Y.130 Hydrogen bonds: A:M.51, A:S.93, A:S.93 Water bridges: A:R.25 Salt bridges: A:H.55, A:R.92

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Richter, H.G.F. et al., Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists to improve physicochemical and ADME properties. Bioorg.Med.Chem.Lett. (2011)

Release Date

2011-01-19

Peptides

Bile acid receptor: A
peptide of Nuclear receptor coactivator 1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

Bile acid receptor

peptide of Nuclear receptor coactivator 1

Related Entries With Identical Sequence